| Market Cap | €19.51B | |
| Enterprise Value | — | |
| Revenue | — | — |
| Gross Profit | — | — |
| EBITDA | — | — |
| Net Income | €1.40B | −7.7% |
| Diluted EPS | — | — |
| Free Cash Flow | — | — |
| DPS (FY2024) | — |
| Trailing yield | — |
| Payout ratio | 31.9% |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20242024-12-31 | — | — | reported |
| FY20232023-12-31 | — | — | reported |
| FY20212021-12-31 | — | — | reported |
| FY20202020-12-31 | — | — | reported |
| Ratio | 2020 | 2021 | 2023 | 2024 | Trend · 4y | vs own |
|---|---|---|---|---|---|---|
| ▾Returns on Capital | ||||||
| Return on Assets | — | 0.46% | — | 0.99% | 75% | |
| ▸DuPont factors (ROE drivers) · 1 ratios | ||||||
| ▸Earnings quality · 3 ratios | ||||||
| ▸Capital allocation · 2 ratios | ||||||
| Line | 2020 | 2021 | 2023 | 2024 |
|---|---|---|---|---|
| SG&A Expense | €1.69B | €2.57B | €3.22B | €3.13B |
| YoY % | +52.5% | +25.3% | -2.9% | |
| Equity Method Income | -€2.9M | €10.8M | €46.3M | €52.4M |
| YoY % | +328.3% | +13.2% | ||
| Pretax Income | €196.7M | €692.9M | €1.72B | €2.05B |
| YoY % | +252.2% | +148.9% | +19.1% | |
| Income Tax | -€65.2M | €134.2M | €172.9M | €615.5M |
| YoY % | +28.8% | +256.0% | ||
| Income from Continuing Operations | €261.9M | €558.6M | €1.55B | €1.44B |
| YoY % | +113.3% | +177.8% | -7.3% | |
| Net Income (incl. NCI) | €261.9M | €558.6M | €1.55B | €1.44B |
| YoY % | +113.3% | +177.8% | -7.3% | |
| Minority Interest (P&L) | -€25.0M | -€33.5M | -€32.3M | -€35.9M |
| Net Income | €236.9M | €525.1M | €1.52B | €1.40B |
| YoY % | +121.6% | +189.4% | -7.7% | |
| EPS (Basic) | €0.35 | €0.37 | — | — |
| YoY % | +6.6% | |||
| EPS (Diluted) | €0.33 | €0.36 | — | — |
| YoY % | +11.0% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
